Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Nogo-66 Receptor Antagonist Peptide (NEP1-40) Administration Promotes Functional Recovery and Axonal Growth After Lateral Funiculus Injury in the Adult Rat

Nogo-66 Receptor Antagonist Peptide (NEP1-40) Administration Promotes Functional Recovery and Axonal Growth After Lateral Funiculus Injury in the Adult Rat

Neurorehabil Neural Repair, 2008 · DOI: 10.1177/1545968307308550 · Published: March 1, 2008

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

The myelin protein Nogo inhibits axon regeneration by binding to its receptor (NgR) on axons. Blocking this receptor with a specific antagonist (NEP1-40) has shown promise in promoting axon growth and functional recovery after spinal cord injury. This study examines the effects of NEP1-40 on recovery and repair after a lateral funiculotomy, a specific type of spinal cord injury that affects the rubrospinal tract (RST), which is important for motor control. Rats with a lateral funiculotomy received either NEP1-40 or a control substance for four weeks. The researchers then assessed their motor and sensory functions, as well as examined their spinal cords to observe axonal growth and changes.

Study Duration
8 weeks
Participants
15 adult female Sprague-Dawley rats
Evidence Level
Not specified

Key Findings

  • 1
    NEP1-40 treatment led to recovery in gait compared to controls.
  • 2
    NEP1-40-treated rats showed improved forelimb usage compared to controls.
  • 3
    There was increased density of rubrospinal tract (RST) axons ipsilaterally rostral to the lesion and contralaterally in both gray and white matter in the NEP1-40 group.

Research Summary

This study investigates the effect of Nogo-66 receptor antagonist peptide (NEP1-40) on functional recovery and axonal growth after lateral funiculus injury in adult rats. The results showed that NEP1-40 treatment is associated with axonal growth and/or diminished dieback of severed RST axons up to the lesion site, and growth of serotonergic and dorsal root axons adjacent to and into the lesion site. NEP1-40 treatment also supported partial recovery of function, indicating that severed rubrospinal axons respond to NEP1-40 treatment but less robustly than corticospinal, raphe-spinal, or dorsal root axons.

Practical Implications

Therapeutic Potential

NgR blockade could be a therapeutic strategy to promote recovery after spinal cord injury.

Combination Therapies

Combining NgR blockade with other treatments, such as neurotrophic factors or cell transplants, may enhance recovery.

Specificity of Axonal Response

Different types of axons may respond differently to NgR blockade, suggesting the need for tailored therapeutic approaches.

Study Limitations

  • 1
    Catheter-induced spinal cord damage
  • 2
    Limited long-distance regeneration of rubrospinal axons
  • 3
    Decline in forelimb usage at the end of the experiment

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury